Inhibition of synergy between NOD2 & TLR signaling pathways underlies the profound efficacy of RIP2 kinase inhibitors in models of inflammatory bowel disease

JOURNAL OF IMMUNOLOGY(2014)

Cited 0|Views17
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined